Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by Kd5513on Mar 07, 2023 12:42pm
72 Views
Post# 35323939

RE:Fellow THTX Shareholders

RE:Fellow THTX ShareholdersDo you happen to have information you could share on how to reach the IR? It may be futile, but worth a shot. Squeeky wheel perhaps?

Looking at the SP it is clear the increase in communication will not effect her in her duties, it may actually help, as it is clear she has no success to speak of since coming. (sadly I would say the same of Paul who we had high hopes for) but clear unless they feel pressure they are not changing course.

I would encourage constant pressure to get them on point so they cannot do anything except address issues that will improve SP.

Sadly what they do is no value add to us based on SP, so they either adjsut or we kick them to the curb at the mtg.

<< Previous
Bullboard Posts
Next >>